ALNY vs PFLT · P/E 76, rev $1.29B vs P/E 12, $1.05B cap
Alnylam Pharmaceuticals Inc (ALNY) versus PennantPark Floating Rate Capital Ltd (PFLT) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
PennantPark Floating Rate Capital Ltd (PFLT) is a asset management company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
PFLT does not have a complete income-statement cache yet.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. PFLT currently screens at market cap $1.05B and trailing P/E 12.4.
Not investment advice. Open the ALNY and PFLT stock pages for the full models.
Not investment advice.